Pinsent Masons represented Teva in the dispute, while Bristows represented Novartis. Teva brought revocation proceedings against two Novartis patents concerning deferasirox, EP 29 64 202 and...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here